BridgeMD
Tests treatment safety and results for Lower Limb Spasticity
Official title Trial to Test the Effectiveness of Vibrotactile Stimulation for Lower Limb Spasticity
ClinicalTrials.gov ID: NCT07447934
What this study is testing
- What it's testing
- The goal of this clinical trial is to find out if Vibrotactile Stimulation (VTS) can help improve mobility and reduce spasticity (muscle stiffness) in people with lower limb spasticity. The study will also look at how VTS affects walking speed.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- ≥6 months following neurologic diagnosis leading to spasticity
- Modified Ashworth Scale (MAS) score of 3 or lower on ankle plantar flexor.
- Ability to stand (with or without assistance) and lie supine.
- Able to understand and comply with study procedures.
You likely can't join if
- Uncontrolled systemic illness or serious medical conditions that could interfere with study procedures.
- Previous surgery to treat spasticity in the affected lower limb.
- Prior Botulinum Toxin (BoNT) therapy in the target limb within 4 months.
- Unstable medication regimens for spasmolysis or muscle relaxation.
- Participation in tone-related treatments (e.g., physiotherapy, TENS, acupuncture) within 4 weeks prior to baseline. If ongoing treatment started more...
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.